Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pectoral Nerve Block for Opioid Consumption in Breast Cancer Surgery
NCT02741232Completed
- Sponsor
- Hôpital Maisonneuve-Rosemont
- Start
- Mar 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine + epinephrine in breast cancer (2 arms), sponsored by Hôpital Maisonneuve-Rosemont. Primary endpoint: Intraoperative remifentanil consumption for the first 30 minutes of surgery. Started Mar 2016; status: completed.
02
Drugs
lidocaine + epinephrine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02741232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02741232.